fda warning letters glp-1 october 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA warning letters

Dr Nirantharakumar reports grants from National Institute for Health Research, MRC Medical Research Council, Diabetes UK, Vifor, and AstraZeneca, and personal fees from Merck Sharp & Dohme, Sanofi, and Boehringer Ingelheim, outside of and unrelated to the submitted work

Once submitted, a licensed medical provider reviews your information and, if appropriate, prescribes GLP-1 medications like semaglutide (commonly found in Ozempic or Wegovy) or tirzepatide (found in Mounjaro or Zepbound)

Patients may experience feeling sick, throwing up, diarrhea, and stomach pain

Your weight loss journey should be safe, informed, and personalized

you dont even think about food

Although the FDA has not communicated that there are any documented links between these medications and pancreatic cancer, studies continue to show connections between the two